Knowledge (XXG)

Peter Boyle (epidemiologist)

Source πŸ“

33: 376:, Brussels (1986–92), Chairman, Epidemiology and Prevention Branch, European Society of Mastology (1989–1997), International Prostate Health Council (1989–2003), Scientific Advisory Board, European School of Oncology, Milan (1992–1999), Chairman, European Commission Expert Committee Cancer Plan (2000–2004), Chairman, Scientific Evaluation Committee, European Tobacco Fund, EC (1999–2002), CEO Advisory Committee, 412:(2000), Award from the President of Israel for Lifetime Contribution to Cancer Research, on Occasion of 50th Anniversary of Israel Cancer Association, Jerusalem (2002), Honorary Member, Hungarian Cancer Society (2003), Honorary Member, European Society for Therapeutic Radiology and Oncology (ESTRO) in 2003, Award of Honorary Doctor of Science by University of Aberdeen (2006) and Elected Fellow of 758: 251:
Boyle was married and had three daughters (all of whom had distinguished herself in medicine), two sons-in-law and three grandchildren. He joked that "the stream of strange foreign medical people arriving for dinner over the years was a clear risk factor in their career choices". He was very fond of
171:
He initially wanted to become a teacher but became fascinated in science. From 1974 to 1977 he worked as a statistician at the University Department of Medicine, Glasgow and the following seven years at the West of Scotland Cancer Surveillance Unit in Glasgow. Here, he developed his lifelong concern
360:
Boyle published more than 500 articles in scientific journals and co-authored some 23 books, including textbooks and cancer atlases. Boyle's specific field of investigation was prevention research. He contributed to the fields of tobacco and lung cancer, breast cancer and prostate cancer. Boyle was
420:(2006), elected full member of ESMO (first non-medical oncologist elected to full membership) in 2006, Gold Award of the Health Promotion Foundation of Poland (2008), received the ESMO Lifetime Achievement Award (2014). 886: 213:
In 2003, he was elected the 4th Director of IARC and moved back to Lyon, a position he held from 2004 to 2008. He stood as a candidate for a second term as Director but was not successful.
891: 861: 192: 525: 210:, EIO. During this time in 2003, the European Code against Cancer was developed and updated to its current third edition under the leadership of Boyle. 261: 417: 405: 381: 277: 881: 216:
In 2009, Boyle was the founding President of a new private research institute, named International Prevention Research Institute in Lyon, France.
206:, Italy to become the first chairperson of the Department of Epidemiology and Biostatistics and Director of the Division of Cancer Control of the 389: 385: 147:. He conducted research on globalisation of cancer, where he showed the dramatic increase of cancer in low- and medium income countries. 866: 163:(BSC in 1974) and received a Doctor of Philosophy degree in Epidemiology in 1985 from the University of Glasgow, Faculty of Medicine). 789: 616: 372:
Boyle was member of many national and international scientific committees, including Secretary, Epidemiology and Prevention Branch,
736: 184: 871: 856: 876: 180: 207: 401: 349: 236: 219:
Beside his main appointments he held several visiting and/or honorary professorships from different Universities, incl.
400:
Boyle received many awards, medals and was member of many scientific societies, among which are Honorary Member of the
413: 325: 564:
Boyle, P; Autier, P; Bartelink, H; Baselga, J; Boffetta, P; Burn, J; Burns, HJ; Christensen, L; et al. (2003).
831: 820: 442: 409: 265: 453: 289: 804: 685: 550: 529: 228: 220: 773: 377: 345: 337: 191:
publications on cancer mortality in Scotland. In 1986, he returned to Europe and became Scientist at the
654: 232: 160: 722: 794: 851: 846: 301: 240: 224: 809: 710: 507: 329: 273: 260:
From 1995 to 2003 he was editor-in-chief (together with Carlo La Vecchia and Alec Walker) of the
199:, and Group Head of SEARCH (Surveillance of Environmental Aspects Related to Cancer in Humans. 733: 587: 499: 491: 280:(2002-2022). Furthermore, he was a member of the editorial boards of the following Journals, 577: 481: 32: 667: 620: 763: 604: 187:
as Instructor and Assistant Professor. During this time Boyle coauthored his first two
486: 469: 840: 740: 511: 305: 144: 104: 566:"European Code Against Cancer and scientific justification: third version (2003)" 799: 672: 642: 134: 825: 814: 436: 341: 188: 137: 495: 582: 565: 591: 503: 252:
Chinese restaurants and died on 23 July 2022 after a long illness in Lyon.
785:
Official website of the International Prevention Research Institute (iPRI)
816:
Interview of Peter Boyle at the IAEA Headquarters in Vienna, October 2009
643:"Peter Boyle, one of the great epidemiologists of our time, dies at 71" 156: 140: 46: 176: 172:
over tobacco and tobacco control, and was drawn into epidemiology.
373: 203: 179:
and worked at the Departments of Biostatistics and Epidemiology,
196: 131: 128: 61: 711:
https://cancerworld.net/peter-boyle-epidemiologist-with-dreams/
89:
Knight's Cross of Order of Merit of Republic of Poland, 2000
361:
an internationally well-known cancer prevention advocate (
784: 617:"company directory of the chambre de commerce de Lyon" 800:
Cancer Letter, Vol.48, No.30, obituary, July 29, 2022
388:(ESMO) (2006–2022), International Affairs Committee, 675:
Cancer Letter, Vol.48, No.30, obituary, 29 July 2022
183:
and the Division of Biostatistics and Epidemiology,
723:
Articles written/co-written by Peter Boyle – Pubmed
384:(2003–2022), Multidisciplinary Oncology Committee, 110: 100: 85: 77: 69: 54: 39: 23: 686:"Dr Peter Boyle (8 June 1951–23 July 2022) – IARC" 887:Harvard T.H. Chan School of Public Health faculty 268:from 1990 to 1994. Boyle was associate editor of 286:Swiss Journal of Social and Preventive Medicine 380:(2002–2022), International Affairs Committee, 673:https://cancerletter.com/obituary/20220729_4/ 336:(Portuguese Journal of Urology) (1996–2022), 143:, (8 June 1951 – 23 July 2022) was a British 8: 270:Oncology and Haematology Literature Service 193:International Agency for Research on Cancer 114:International Prevention Research Institute 31: 20: 892:Fellows of the Royal Society of Edinburgh 581: 485: 262:Journal of Epidemiology and Biostatistics 159:, Scotland and studied statistics at the 526:"EIO homepage, history of the Institute" 463: 461: 418:Royal College of Physicians of Edinburgh 406:Order of Merit of the Republic of Poland 382:American Association for Cancer Research 278:British Journal of Urology International 429: 272:from 1993 to 1998 and for the journals 810:Cancerworld Magazine, Obituaries, 2022 713:Cancerworld Magazine, Obituaries, 2022 663: 652: 390:American Society of Clinical Oncology 386:European Society for Medical Oncology 7: 827:Interview of Peter Boyle, ASCO, 2009 862:Alumni of the University of Glasgow 81:Contribution to cancer epidemiology 805:IARC, press release, July 28, 2022 605:IARC press release NΒ°148, May 2003 16:British epidemiologist (1951–2022) 14: 468:Watts, Geoff (12 November 2022). 756: 326:Journal of Gynecologic Oncology 181:Harvard School of Public Health 882:Harvard Medical School faculty 208:European Institute of Oncology 1: 487:10.1016/S0140-6736(22)02178-X 438:Interview with P. Boyle, 2007 402:Argentine Medical Association 774:Peter Boyle (epidemiologist) 552:European Code against Cancer 363:European Code against Cancer 318:Journal of Radiation Therapy 185:Dana–Farber Cancer Institute 414:Academy of Medical Sciences 367:The Globalisation of Cancer 908: 867:British cancer researchers 416:(2006), Elected Fellow of 410:Royal Society of Edinburgh 404:(1996), Knight's Cross of 266:European Journal of Cancer 310:European R and D Database 290:British Journal of Cancer 282:Cancer Causes and Control 118: 93: 30: 229:University of Pittsburgh 221:University of Birmingham 151:Early life and education 872:British epidemiologists 857:Scientists from Glasgow 378:American Cancer Society 247:Personal life and death 237:University of Innsbruck 877:Scottish statisticians 734:University of Aberdeen 662:Cite journal requires 346:Nature Reviews Urology 58:23 July 2022 (aged 71) 583:10.1093/annonc/mdg305 454:University of Glasgow 233:University of Glasgow 202:In 1991, he moved to 175:In 1984, he moved to 161:University of Glasgow 338:Breast Cancer Online 322:European Cancer News 302:The Breast (journal) 276:(1999-2022) and the 241:University of Oxford 649:(30). 29 July 2022. 225:University of Milan 795:Cancer World, 2005 570:Annals of Oncology 408:(2000), Fellow of 350:Molecular Oncology 330:Annals of Oncology 274:Annals of Oncology 155:Boyle was born in 396:Awards and honors 122: 121: 95:Scientific career 899: 828: 817: 760: 759: 743: 739:16 July 2012 at 731: 725: 720: 714: 708: 702: 701: 699: 697: 690:www.iarc.who.int 682: 676: 671: 665: 660: 658: 650: 639: 633: 632: 630: 628: 619:. Archived from 613: 607: 602: 596: 595: 585: 561: 555: 548: 542: 541: 539: 537: 528:. Archived from 522: 516: 515: 489: 465: 456: 451: 445: 439: 434: 35: 21: 907: 906: 902: 901: 900: 898: 897: 896: 837: 836: 826: 815: 781: 780: 779: 761: 757: 752: 747: 746: 732: 728: 721: 717: 709: 705: 695: 693: 684: 683: 679: 661: 651: 641: 640: 636: 626: 624: 623:on 20 July 2011 615: 614: 610: 603: 599: 576:(7): 973–1005. 563: 562: 558: 549: 545: 535: 533: 524: 523: 519: 480:(10364): 1676. 467: 466: 459: 452: 448: 437: 435: 431: 426: 398: 358: 356:Scientific work 258: 249: 169: 153: 65: 59: 50: 44: 26: 17: 12: 11: 5: 905: 903: 895: 894: 889: 884: 879: 874: 869: 864: 859: 854: 849: 839: 838: 835: 834: 823: 812: 807: 802: 797: 792: 787: 762: 755: 754: 753: 751: 750:External links 748: 745: 744: 726: 715: 703: 692:. 23 July 2022 677: 664:|journal= 634: 608: 597: 556: 543: 532:on 29 May 2009 517: 457: 446: 428: 427: 425: 422: 397: 394: 357: 354: 320:(1996–2022), 257: 254: 248: 245: 168: 165: 152: 149: 145:epidemiologist 120: 119: 116: 115: 112: 108: 107: 102: 98: 97: 91: 90: 87: 83: 82: 79: 78:Known for 75: 74: 71: 67: 66: 60: 56: 52: 51: 45: 41: 37: 36: 28: 27: 24: 15: 13: 10: 9: 6: 4: 3: 2: 904: 893: 890: 888: 885: 883: 880: 878: 875: 873: 870: 868: 865: 863: 860: 858: 855: 853: 850: 848: 845: 844: 842: 833: 829: 824: 822: 818: 813: 811: 808: 806: 803: 801: 798: 796: 793: 791: 788: 786: 783: 782: 777: 776: 775: 769: 765: 749: 742: 741:archive.today 738: 735: 730: 727: 724: 719: 716: 712: 707: 704: 691: 687: 681: 678: 674: 669: 656: 648: 644: 638: 635: 622: 618: 612: 609: 606: 601: 598: 593: 589: 584: 579: 575: 571: 567: 560: 557: 554: 553: 547: 544: 531: 527: 521: 518: 513: 509: 505: 501: 497: 493: 488: 483: 479: 475: 471: 470:"Peter Boyle" 464: 462: 458: 455: 450: 447: 444: 440: 433: 430: 423: 421: 419: 415: 411: 407: 403: 395: 393: 392:(2008–2022). 391: 387: 383: 379: 375: 370: 368: 364: 355: 353: 352:(2006–2022). 351: 348:(2004–2022), 347: 344:(2003–2022), 343: 340:(1999–2022), 339: 335: 332:(1996–2022), 331: 328:(1996–2022), 327: 323: 319: 316:(1995–2022), 315: 311: 308:(1991–2022), 307: 306:Oral Oncology 303: 299: 295: 292:(1990–1997), 291: 288:(1990–2022), 287: 284:(1990–1994), 283: 279: 275: 271: 267: 263: 255: 253: 246: 244: 243:(2003–2022). 242: 238: 235:(1998–2022), 234: 231:(1996–2002), 230: 227:(1996–2004), 226: 223:(1996–2022), 222: 217: 214: 211: 209: 205: 200: 198: 194: 190: 186: 182: 178: 173: 166: 164: 162: 158: 150: 148: 146: 142: 139: 136: 133: 130: 126: 117: 113: 109: 106: 103: 99: 96: 92: 88: 84: 80: 76: 72: 68: 63: 57: 53: 48: 42: 38: 34: 29: 22: 19: 772: 771: 770:profile for 767: 729: 718: 706: 694:. Retrieved 689: 680: 655:cite journal 646: 637: 625:. Retrieved 621:the original 611: 600: 573: 569: 559: 551: 546: 534:. Retrieved 530:the original 520: 477: 473: 449: 432: 399: 371: 366: 362: 359: 333: 321: 317: 313: 309: 298:BPH Observer 297: 296:(1990–99), 294:Prospectives 293: 285: 281: 269: 259: 250: 218: 215: 212: 201: 174: 170: 154: 124: 123: 111:Institutions 105:Epidemiology 94: 18: 852:2022 deaths 847:1951 births 696:15 November 324:(1996–98), 314:Lung Cancer 312:(1993–98), 304:(1991–97), 300:(1990–99), 264:and of the 195:, IARC, in 135:FRCPS(Glas) 125:Peter Boyle 70:Nationality 43:8 June 1951 25:Peter Boyle 841:Categories 627:20 October 536:20 October 474:The Lancet 424:References 138:FRCP(Edin) 49:, Scotland 790:Biovision 512:253451443 496:0140-6736 737:Archived 592:12853336 504:36372087 239:(1998), 64:, France 832:YouTube 821:YouTube 766:has an 764:Scholia 443:YouTube 256:Service 157:Glasgow 141:FMedSci 73:British 47:Glasgow 768:author 590:  510:  502:  494:  342:Lancet 189:Lancet 177:Boston 167:Career 101:Fields 86:Awards 508:S2CID 374:EORTC 365:, or 204:Milan 698:2022 668:help 629:2009 588:PMID 538:2009 500:PMID 492:ISSN 197:Lyon 132:FFPH 129:FRSE 62:Lyon 55:Died 40:Born 830:on 819:on 578:doi 482:doi 478:400 441:on 369:). 334:URO 843:: 688:. 659:: 657:}} 653:{{ 647:48 645:. 586:. 574:14 572:. 568:. 506:. 498:. 490:. 476:. 472:. 460:^ 127:, 778:. 700:. 670:) 666:( 631:. 594:. 580:: 540:. 514:. 484::

Index


Glasgow
Lyon
Epidemiology
FRSE
FFPH
FRCPS(Glas)
FRCP(Edin)
FMedSci
epidemiologist
Glasgow
University of Glasgow
Boston
Harvard School of Public Health
Dana–Farber Cancer Institute
Lancet
International Agency for Research on Cancer
Lyon
Milan
European Institute of Oncology
University of Birmingham
University of Milan
University of Pittsburgh
University of Glasgow
University of Innsbruck
University of Oxford
Journal of Epidemiology and Biostatistics
European Journal of Cancer
Annals of Oncology
British Journal of Urology International

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑